Results 6,861-6,880 of 9,393 for speaker:Alex White

Written Answers — Department of Health: Medical Card Applications (6 Nov 2012)

Alex White: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.

Written Answers — Department of Health: Medical Card Appeals (6 Nov 2012)

Alex White: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.

Written Answers — Department of Health: Medical Card Applications (6 Nov 2012)

Alex White: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.

Written Answers — Department of Health: Medical Card Eligibility (6 Nov 2012)

Alex White: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.

Written Answers — Department of Health: Medicinal Products (6 Nov 2012)

Alex White: Under the Health (Pricing and Supply of Medical Goods) Bill, the Irish Medicines Board has statutory responsibility for establishing and publishing a list of interchangeable medicinal products in respect of which it is satisfied that all the medicinal products which fall into a group of interchangeable medicinal products are, for prescription purposes, interchangeable with each other. It is...

Written Answers — Department of Health: Medical Card Applications (6 Nov 2012)

Alex White: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.

Written Answers — Department of Health: Health Service Expenditure (6 Nov 2012)

Alex White: I propose to take Questions Nos. 1024 to 1027, inclusive, together. The HSE estimates that expenditure in 2012 on drugs and non-drug items (dressings, etc.) under the GMS and community drug schemes, including mark ups and dispensing fees will be approximately €1.7 billion.In addition, about €300m will be spent on drugs and medicines used in public hospitals. The HSE estimates...

Written Answers — Department of Health: Medicinal Products (6 Nov 2012)

Alex White: The Health (Pricing and Supply of Medical Goods) Bill 2012 provides for the introduction of a system of generic substitution and reference pricing. Generic substitution allows pharmacists to substitute a cheaper generic equivalent, at the patient’s request, when a more expensive product has been prescribed. Reference pricing involves setting a common reimbursement amount for selected...

Written Answers — Department of Health: Medical Cards (6 Nov 2012)

Alex White: The Health (Pricing and Supply of Medical Goods) Bill 2012 provides for the introduction of a system of generic substitution and reference pricing. Generic substitution allows pharmacists to substitute a cheaper generic equivalent, at the patient’s request, when a more expensive product has been prescribed. Reference pricing involves setting a common reimbursement amount for selected...

Written Answers — Department of Health: Medical Card Appeals (6 Nov 2012)

Alex White: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.

Written Answers — Department of Health: Drugs Payment Scheme (6 Nov 2012)

Alex White: The HSE recently received an application for Kalydeco's inclusion under the Community Drugs Scheme. In accordance with normal procedures, the National Centre for Pharmacoeconomics must conduct a Health Technology Assessment (HTA) on this product which will consider if the drug is cost effective at the price offered to the HSE. No reimbursement decision will be made until the HTA has been...

Written Answers — Department of Health: Medicinal Products (6 Nov 2012)

Alex White: My Department has been informed by the Irish Medicines Board (IMB) that it is in receipt of a market authorisation request from a manufacturer under the EU Mutual Recognition Procedure for a medicinal product containing Cannabis extract. This product is indicated for the relief of symptoms of spasticity for people with multiple sclerosis. Clinical trials in Ireland relating to this product...

Written Answers — Department of Health: Medical Cards (6 Nov 2012)

Alex White: I propose to take Questions Nos. 1040 and 1166 together. In the current financial environment the Health Service Executive (HSE) is facing a challenge to deliver services in a way that will minimise any adverse impact on patients and continue to protect, as far as possible, the most vulnerable citizens. Unfortunately, it has become necessary for the HSE to suspend certain products from its...

Written Answers — Department of Health: General Medical Services Scheme (6 Nov 2012)

Alex White: A General Medical Services (GMS) panel can become vacant for a number of reasons, some of which can be foreseen and planned for, such as retirements or resignations, and others may arise due to unforeseen circumstances, for example sudden death or sudden incapacity of a general practitioner (GP). In the case of foreseen/planned vacancies, the HSE will endeavour to put appropriate...

Written Answers — Department of Health: Medical Card Application Numbers (6 Nov 2012)

Alex White: At the end of August 2012, a total of 1,836,604 medical cards and 131,318 GP Visit cards have been issued. Nearly 43% of the national population currently has free access to GP services under the GMS Scheme (40% medical card & 2.9% GP visit card). This compares to 31% as at end 2007.

Written Answers — Department of Health: Medical Card Eligibility (6 Nov 2012)

Alex White: Persons aged 16 - 25 years, including students, who are eligible for medical card/GP visit cards are: -Persons who are dependants of medical card/GP visit card holders; -Financially independent persons with means who are within the medical card/GP visit card guidelines; -Cases of undue hardship where it would be unduly burdensome to them to provide General Practitioner or medical and...

Written Answers — Department of Health: Drugs Payment Scheme (6 Nov 2012)

Alex White: Following intensive negotiations with the Irish Pharmaceutical Healthcare Association (IPHA), the Department of Health and the HSE have reached agreement on a major new deal on the cost of drugs in the State. This deal has a value in excess of €400 million over the next three years and will mean, amongst other things, greater access to new cutting-edge drugs. The HSE is finalising...

Written Answers — Department of Health: Medical Card Applications (6 Nov 2012)

Alex White: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.

Written Answers — Department of Health: Medical Card Applications (6 Nov 2012)

Alex White: As this is a service matter it has been referred to the Health Service Executive for direct reply to the Deputy.

Written Answers — Department of Health: Long-Term Illness Scheme Eligibility (6 Nov 2012)

Alex White: I propose to take Questions Nos. 1111 to 1113, inclusive, and 1173 together. There are no plans to extend the list of conditions covered by the Long Term Illness Scheme. Under the Drug Payment Scheme, no individual or family pays more than €132 per calendar month towards the cost of approved prescribed medicines. The scheme significantly reduces the cost burden for families and...